In our study, carvacrol upregulated ABCG2 expression by ~6.7-fold in MCF-7 (HR+ BC) cells, whereas it downregulated ABCG2 expression by ~0.2-fold in MDA-MB-231 (TNBC) cells (Figure 7). The gene discussed is ABCG2; the disease is breast cancer.